Intravesical Bacillus Calmette-Guérin (BCG)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Intravesical Bacillus Calmette-Guérin (BCG), covering 2026-06-05 to 2026-06-05. Get the full timeline:
Most recent: Clinical Trial Update: A Study of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants With BCG-naïve High-risk Non-muscle Invasive Bladder Cancer (HR-NMIBC) [Phase 3]